404
+1-313-307-4176
sales@stratviewresearch.com
Proton Pump Inhibitors (PPIs) Market Report
Proton Pump Inhibitors (PPIs) Market Size, Share, Trend, Forecast, & Industry Analysis: 2022-2028
"The global proton pump inhibitor (PPIs) market is projected to grow from USD 2.99 billion in 2021 to USD 4.12 billion by 2028 at a CAGR of over 4.63% during the forecast period of 2022-2028."
-Market-Size_14072.jpg)
Want to get a free sample? Register Here
What are proton pump initiators (PPIs)?
Proton pump initiators (PPIs) are drugs that are primarily used for the profound and prolonged reduction of stomach acid levels in individuals suffering from hyperacidity, gastroesophageal reflux disease, and ulcers.
PPIs possess a unique mechanism of action as they are given in an inactive form that is lipophilic and readily crosses cell membranes into intracellular compartments such as the parietal cell canaliculus with an acidic environment, then the inactive drug is rearranged after protonation into its active form in an acidic environment, which irreversibly blocks the gastric proton pump of gastric parietal cells.
Market Dynamics
Growing acceptance of novel drug delivery systems and increasing prevalence of peptic ulcers and other gastrointestinal disorders are some of the key factors augmenting the market growth. Rising consumer acceptance of novel drug delivery systems and new product launches offer immense growth opportunities to the market players.
However, consumers in isolated regions tend to prefer the common antacids to deal with gastrointestinal and ulcer disorders, which is likely to hinder the product demand.
Many scientists have found that PPIs have increased the risk of COVID-19 in patients taking these medications. In 2020, the researchers of the American Journal of Gastroenterology carried out research in which more than 53,000 people taking PPIs participated, of which 3,386 were tested positive for COVID-19. This is likely to negatively impact market growth as the patients undergoing PPI therapy are recommended to consume less medication and avoid these medications unless it is an emergency.
Want to get a free sample? Register Here
Key players operating in the global proton pump inhibitors market are:
Note: The above list does not necessarily include all the top players in the market.
Are you the leading player in this market? We would love to include your name. Write to us at sales@stratviewresearch.com
"The esomeprazole segment accounted for the largest market share."
Based on drug type, the global proton pump inhibitors market has been bifurcated into over-the-counter drugs and prescription drugs. The over-the-counter drugs segment is further categorized into omeprazole, lansoprazole, esomeprazole, and others. Among these, esomeprazole under the OTC drug segment garnered the highest market share in 2021 and is likely to grow at a healthy CAGR during the forecast timeline. Esomeprazole is mainly indicated to treat the symptoms of heartburn, Gastroesophageal Reflux Disease (GERD), and other disorders such as excessive stomach acids, thus bolstering segment growth.
"North America accounted for the largest market share."
By region, the North American market accounted for the largest market share in 2021 and is estimated to grow at a steady CAGR during the assessment period. This can be attributed to increasing approvals of proton pump inhibitor products and the increasing prevalence of GERD in the US, Canada, and Mexico, which proliferates industry growth in the region. Moreover, GERD affects almost 20% of adults in the US, thereby making the disease an important concern, which propels regional growth.
Want to get a free sample? Register Here
This strategic assessment report, from Stratview Research, provides a comprehensive analysis that reflects today’s proton pump inhibitors market realities and future market possibilities for the forecast period. The report segments and analyzes the market in the most detailed manner in order to provide a panoramic view of the market. The vital data/information provided in the report can play a crucial role for market participants as well as investors in the identification of the low-hanging fruits available in the market as well as to formulate growth strategies to expedite their growth process.
This report offers high-quality insights and is the outcome of detailed research methodology comprising extensive secondary research, rigorous primary interviews with industry stakeholders and validation and triangulation with Stratview Research’s internal database and statistical tools. More than 1,000 authenticated secondary sources, such as company annual reports, fact book, press release, journals, investor presentation, white papers, patents, and articles have been leveraged to gather the data. We conducted more than 10 detailed primary interviews with the market players across the value chain in all four regions and with industry experts to obtain both the qualitative and quantitative insights.
This report provides market intelligence in the most comprehensive way. The report structure has been kept such that it offers maximum business value. It provides critical insights into market dynamics and will enable strategic decision-making for existing market players as well as those willing to enter the market.
What deliverables will you get in this report?
|
Key questions this report answers |
Relevant contents in the report |
|
How big is the sales opportunity? |
In-depth analysis of the Proton Pump Inhibitors Market |
|
How lucrative is the future? |
Market forecast and trend data and emerging trends |
|
Which regions offer the best sales opportunities? |
Global, regional and country level historical data and forecasts |
|
Which are the most attractive market segments? |
Market segment analysis and forecast |
|
Which are the top players and their market positioning? |
Competitive landscape analysis, Market share analysis |
|
How complex is the business environment? |
Porter’s five forces analysis, PEST analysis, Life cycle analysis |
|
What are the factors affecting the market? |
Drivers & challenges |
|
Will I get the information on my specific requirement? |
10% free customization |
The market is segmented into the following categories:
By Drug Type
By Disease Type
By Distribution Channel Type
By Region
This report studies the market covering a period of 12 years of trend and forecast. The report provides detailed insights into the market dynamics to enable informed business decision-making and growth strategy formulation based on the opportunities present in the market.
|
Report - Features |
|
|---|---|
|
Market Segmentation |
4 |
|
Regions Covered |
5 |
|
Countries/Sub-Regions Covered |
16 |
|
No. of Figures & Tables |
>90 |
|
Company Profiles |
10 |
With this detailed report, Stratview Research offers one of the following free customization options to our respectable clients:
Custom Research: Stratview Research offers custom research services across sectors. In case of any custom research requirement related to market assessment, competitive benchmarking, sourcing and procurement, target screening, and others, please send your inquiry to sales@stratviewresearch.com
Proton pump initiators (PPIs) are drugs that are primarily used for profound and prolonged reduction of stomach acid levels in individuals suffering from hyperacidity, gastroesophageal reflux disease, and ulcers.
The proton pump inhibitors market is expected to witness impressive growth of 4.63% CAGR in the foreseeable future.
AstraZeneca PLC/AB (UK), Bayer AG (Germany), Pfizer Inc. (The U.S), Cadila Pharmaceuticals Limited (India), Eisai Pharmaceuticals India Pvt. Ltd (India), Santarus, Inc. (The U.S), Wyeth, LLC (The U.S), Janssen Pharmaceutical (Belgium), Takeda Pharmaceutical Company Limited (Japan) and Sanofi S.A. (France) are among the key players in the proton pump inhibitors market.
The proton pump inhibitors market size is expected to reach USD 4.12 billion by 2028.
North America accounted for the largest share of proton pump inhibitors market in 2021.
Esomeprazole, under the OTC drug segment garnered the highest share in the proton pump inhibitors market.
Growing acceptance of novel drug delivery systems and increasing prevalence of peptic ulcers and other gastrointestinal disorders are the factors driving the growth of proton pump inhibitors market.
Proton Pump Inhibitors (PPIs) companies, Proton Pump Inhibitors (PPIs) vendors, Hospitals, Pharmaceutical companies, R&D organizations are the target audience in the proton pump inhibitors market.
WE ACCEPT
